You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Replication Defective

Showing 1 - 25 of 913
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autosomal Recessive Ichthyosis Trial in Rancho Santa Margarita (KB105, Placebo)

Not yet recruiting
  • Autosomal Recessive Ichthyosis
  • KB105
  • Placebo
  • Rancho Santa Margarita, California
    Mission Dermatology
Feb 20, 2023

Cystic Fibrosis Trial in New Haven (KB407 (Nebulization))

Not yet recruiting
  • Cystic Fibrosis
  • KB407 (Nebulization)
  • New Haven, Connecticut
    Yale University School of Medicine
Aug 15, 2022

Alpha 1-Antitrypsin Deficiency Trial in Charleston (KB408 (Nebulization))

Not yet recruiting
  • Alpha 1-Antitrypsin Deficiency
  • KB408 (Nebulization)
  • Charleston, South Carolina
    Medical University of South Carolina
Sep 20, 2023

COVID-19 Trial in Lianyungang (batch 1 of Ad5-nCoV, batch 2 of Ad5-nCoV, batch 3 of Ad5-nCoV)

Completed
  • COVID-19
  • batch 1 of Ad5-nCoV
  • +2 more
  • Lianyungang, Jiangsu, China
    Guanyun Center for Disease Control and Prevention
Apr 5, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN, Placebo Tablets, Norovirus GI.1 Norwalk Virus Inoculum)

Recruiting
  • Norovirus Infections
  • VXA-G1.1-NN
  • +2 more
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    WCCT Global, Inc.
Sep 19, 2022

COVID-19 Trial in Nanjing (Ad5-nCoV-IH, Ad5-nCoV-IM, CoronaVac)

Active, not recruiting
  • COVID-19
  • Ad5-nCoV-IH
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Aug 12, 2022

Optimising Cohorts for HIV Cure Interventions

Recruiting
  • HIV-1-infection
  • no intervention
  • Prahran, Victoria, Australia
    Alfred Health
May 1, 2023

COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)

Not yet recruiting
  • COVID-19
  • Pfizer-BioNTech Standard dose
  • +5 more
  • Bandung, West Java, Indonesia
  • +2 more
Nov 30, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Prostate Cancer Trial in Birmingham (AdNRGM)

Completed
  • Prostate Cancer
  • AdNRGM
  • Birmingham, West Midlands, United Kingdom
    Queen Elizabeth Hospital Birmingham, University Hospitals Birmin
Nov 2, 2021

Rabies, Rabies Immunisation Trial in Decatur (ChAd155-RG, Placebo, Rabies Vaccine)

Active, not recruiting
  • Rabies
  • Rabies Immunisation
  • ChAd155-RG
  • +2 more
  • Decatur, Georgia
    Emory Vaccine Center - The Hope Clinic
Aug 18, 2022

COVID-19 Trial in Rome, Verona (GRAd-COV2)

Completed
Has Results
  • COVID-19
  • GRAd-COV2
  • Rome, Italy
  • +1 more
Feb 7, 2022

SARS-CoV-2 Virus Infection Trial in United Kingdom (VLA2001, AZD1222, VLA2001 - adolescent part)

Active, not recruiting
  • SARS-CoV-2 Virus Infection
  • VLA2001
  • +3 more
  • Barnsley, United Kingdom
  • +30 more
Oct 17, 2022

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452))

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • Birmingham, Alabama
  • +15 more
Oct 28, 2021

COVID-19 Trial in Nanjing (Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell))

Completed
  • COVID-19
  • Recombinant SARS-CoV-2 Ad5 vectored vaccine
  • Inactive SARS-CoV-2 vaccine (Vero cell)
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Mar 28, 2022

COVID-19 Trial in United States (VXA-CoV2-1.1-S, Placebo Tablets)

Recruiting
  • COVID-19
  • Long Beach, California
  • +3 more
Sep 19, 2022

Malignant Glioma, Glioblastoma Multiforme Trial in Ann Arbor (Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L)

Completed
  • Malignant Glioma
  • Glioblastoma Multiforme
  • Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L
  • Ann Arbor, Michigan
    University of Michigan Health System Department of Neurosurgery
Aug 25, 2021

HIV-1-infection Trial in Nairobi

Recruiting
  • HIV-1-infection
    • Nairobi, Kenya
      Kenya Medical Research Institute
    Jul 19, 2021

    COVID-19 Trial in Nanjing (recombinant Ad5 vectored COVID-19 vaccine, RBD-based protein subunit vaccine (ZF2001) against

    Completed
    • COVID-19
    • recombinant Ad5 vectored COVID-19 vaccine
    • +2 more
    • Nanjing, Jiangsu, China
      Jiangsu Provincial Center for Diseases Control and Prevention
    Mar 28, 2022

    MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

    Not yet recruiting
    • MSI-H/dMMR Gastroesophageal-junction Cancer
    • MSI-H/dMMR Gastric Cancer
    • (no location specified)
    Oct 30, 2023

    Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

    Active, not recruiting
    Has Results
    • Metastatic Non-small Cell Lung Cancer
    • Metastatic Triple-negative Breast Cancer
    • ADV/HSV-tk
    • +3 more
    • Houston, Texas
      Houston Methodist Cancer Center
    Dec 28, 2022

    Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)

    Not yet recruiting
    • Colonic Neoplasms
    • Dostarlimab
    • +2 more
    • (no location specified)
    May 3, 2023

    Correction of Nonsense Mutations in Cystic Fibrosis

    Recruiting
    • Cystic Fibrosis
    • smear of nasal fossae
    • Amiens, France
    • +7 more
    Nov 17, 2020